摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3R)-tert-butyl methyl 3-benzyloxycarbonylaminoglutarate | 83436-44-6

中文名称
——
中文别名
——
英文名称
(3R)-tert-butyl methyl 3-benzyloxycarbonylaminoglutarate
英文别名
5-O-tert-butyl 1-O-methyl (3R)-3-(phenylmethoxycarbonylamino)pentanedioate
(3R)-tert-butyl methyl 3-benzyloxycarbonylaminoglutarate化学式
CAS
83436-44-6
化学式
C18H25NO6
mdl
——
分子量
351.4
InChiKey
GXZLZKSJMNEKGI-CQSZACIVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    471.2±45.0 °C(Predicted)
  • 密度:
    1.144±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    25
  • 可旋转键数:
    11
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    90.9
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (3R)-tert-butyl methyl 3-benzyloxycarbonylaminoglutaratesodium hydroxideN,N'-二环己基碳二亚胺 作用下, 以 甲醇二氯甲烷 为溶剂, 反应 2.5h, 生成 (Benzyloxycarbonyl)-β-homo-L-aspartic acid α-pentachlorophenyl ester β-tert-butyl ester
    参考文献:
    名称:
    Synthesis of gastrin antagonists, analogs of the C-terminal tetrapeptide of gastrin, by introduction of a .beta.-homo residue
    摘要:
    A series of analogues of Boc-Trp-Leu-Asp-Phe-NH2, a potent gastrin agonist, were synthesized by introducing a beta-homo residue in the sequence. These compounds were tested in vivo on acid secretion, in the anesthetized rat, and for their ability to inhibit binding of labeled gastrin to its receptors on gastric mucosal cells. These analogues behaved as gastrin antagonists. The most potent compounds in this series were Boc-Trp-Leu-beta-homo-Asp-NHCH2C6H5 (10) (IC50 = 1 microM, ED50 = 0.2 mg/kg), Boc-Trp-Leu-beta-homo-Asp-NHCH2CH2C6H5 (11) (IC50 = 0.75 microM, ED50 = 0.5 mg/kg), Boc-Trp-Leu-beta-homo-Asp-Phe-NH2 (12) (IC50 = 1.5 microM, ED50 = 0.1 mg/kg), and Boc-Trp-Leu-beta-homo-Asp-D-Phe-NH2 (13) (IC50 = 2 microM, ED50 = 0.1 mg/kg). We could demonstrate the importance of the region of the peptide bond between leucine and aspartic acid and of the structure of the C-terminal dipeptide Asp-Phe-NH2, for exhibiting biological activity on acid secretion.
    DOI:
    10.1021/jm00123a003
  • 作为产物:
    参考文献:
    名称:
    手性1,3,6-三取代2,4-二氧六氢嘧啶类化合物:由天冬氨酸衍生物方便的立体选择性合成
    摘要:
    通过使天冬氨酸衍生物与异氰酸酯反应,然后环化所得的尿素,并在N1位烷基化,可以容易地合成手性的1,3,6-三取代的2,4-二氧六氢嘧啶。
    DOI:
    10.1016/j.tetlet.2007.03.066
点击查看最新优质反应信息

文献信息

  • Synthesis and Configuration Confirmation of the ATHOD Fatty Amino Acid Residue in the Burkholdines
    作者:Toma Kadowaki、Rin Kainuma、Seiya Kato、Hiroyuki Konno
    DOI:10.1021/acs.jnatprod.2c00469
    日期:2022.8.26
    Eight possible diastereomers of the 3-amino-5,6,7-trihydroxy octadecanoic acid (ATHOD) moiety of the burkholdines (Bks) have been synthesized and their configurations assigned. Though the relative configuration of the triol in the ATHOD residue of the Bks was proposed to be anti–anti–anti in the literature, 1H NMR spectra of our synthesized anti–anti–anti ATHOD derivative was inconsistent with that
    已经合成了伯克霍尔定 (Bks) 的 3-氨基-5,6,7-三羟基十八烷酸 (ATHOD) 部分的八种可能的非对映异构体,并分配了它们的构型。虽然在文献中提出 Bks 的 ATHOD 残基中三醇的相对构型是反抗反抗的,但我们合成的反抗反抗的1 H NMR 光谱ATHOD 衍生物与分离的 ATHOD 残基的衍生物不一致,表明文献中对该残基的相对构型的分配是不正确的。然而,通过使用 Kishi 的 NMR 数据库方法将我们的 ATHOD 衍生物的 NMR 数据与配置定义的 2-氨基-4-戊醇样品的 NMR 数据进行比较,我们得出结论 ATHOD 部分的绝对构型为 (3 R ,5 S , 6 R ,7 S )。此外,我们发现存在于 occidiofungins A-D 中的 ATHOD 残基具有与所有 Bks 中相同的构型。
  • N- and C-terminal modifications of negamycin
    作者:B Raju、Kathleen Mortell、Sampathkumar Anandan、Hardwin O'Dowd、Hongwu Gao、Marcela Gomez、Corinne Hackbarth、Charlotte Wu、Wen Wang、Zhengyu Yuan、Richard White、Joaquim Trias、Dinesh V Patel
    DOI:10.1016/s0960-894x(03)00393-7
    日期:2003.7
    Negamycin 1 is a bactericidal antibiotic with activity against Gram-negative bacteria, and served as a template in an antibiotic discovery program. An orthogonally protected beta-amino acid derivative 3a was synthesized and used in parallel synthesis of negamycin derivatives on solid support. This advanced intermediate was also used for N- and C-terminal modifications using solution-phase methodologies. The N-terminal modifications have resulted in the identification of active analogues, whereas the C-terminal modifications resulted in complete loss of antibacterial activity. The N-methyl negamycin analogue, 19a, inhibits protein synthesis (IC50 = 2.3 muM), has antibacterial activity (Escherichia coli, MIC = 16 mug/mL), and is efficacious in an E. coli murine septicemia model (ED50 = 16.3 mg/kg). (C) 2003 Elsevier Science Ltd. All rights reserved.
  • Stereocontrolled synthesis of (+)-negamycin from an acyclic homoallylamine by 1,3-asymmetric induction
    作者:Yi Fong Wang、Toshio Izawa、Susumu Kobayashi、Masaji Ohno
    DOI:10.1021/ja00387a060
    日期:1982.11
  • Peptidyl β-homo-aspartals: Specific inhibitors of interleukin-1β converting enzyme and its homologues (caspases)
    作者:Sándor Bajusz、Irén Fauszt、Klára Németh、Éva Barabás、Attila Juhász、Miklós Patthy
    DOI:10.1016/s0960-894x(98)00244-3
    日期:1998.6
    Inhibition of interleukin-1 beta converting enzyme (ICE), apopain, papain, thrombin and trypsin with substrate like peptidyl L- and D-alpha-aldehydes and their L-beta-homo-aldehyde analogues was investigated. The L-beta-homo-aspartals appear to be specific inhibitors for ICE and its homologues; the other enzymes were not inhibited with such L-beta-homo aldehydes. Papain shows tolerance for D-residues at P-1 depending on their chiral stability. (C) 1998 Elsevier Science Ltd. All rights reserved.
  • CROSSLEY, MAXWELL J.;FISHER, MEGAN L.;POTTER, JEFFREY J.;KUCHEL, PHILIP W+, J. CHEM. SOC. PERKIN TRANS. PT 1 ,(1990) N, C. 2363-2369
    作者:CROSSLEY, MAXWELL J.、FISHER, MEGAN L.、POTTER, JEFFREY J.、KUCHEL, PHILIP W+
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐